The Zhejiang Huahai Pharmaceutical headquarters and production complex in Linhai, Zhejiang province, China. The generic drug exporter may have produced a heart treatment containing a potential carcinogen for four years before US regulators intervened. Photo: Bloomberg

How US drug regulator overruled inspector and let tainted pills from China be used by US patients

  • Potential carcinogen may have been in generic version of blood pressure drug valsartan made by Zhejiang Huahai Pharmaceutical for four years
  • Chinese companies account for almost one in every 10 generic drugs cleared by the United States Federal Drug Administration
Topic |   Health and wellness

TOP PICKS

The Zhejiang Huahai Pharmaceutical headquarters and production complex in Linhai, Zhejiang province, China. The generic drug exporter may have produced a heart treatment containing a potential carcinogen for four years before US regulators intervened. Photo: Bloomberg
READ FULL ARTICLE